Every 10-Q that HealthEquity, Inc (HQY) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow HQY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HQY filings page.
HealthEquity, Inc. (HQY) reported solid growth for the quarter ended July 31, 2026. Total revenue was $350.7 million, up 8% from a year earlier, driven by higher custodial, service, and interchange revenue. Net income rose to $65.6 million from $59.9 million, and diluted EPS increased to $0.78 from $0.68.
Custodial revenue grew 10% on a higher average yield on HSA cash (3.83% vs. 3.51%) and modest balance growth. Total HSA Assets reached $37.9 billion, up 14% year over year, with $17.4 billion in HSA cash and $20.6 billion in HSA investments. Total Accounts were 17.8 million, including 10.7 million HSAs.
Operating cash flow for the six months was strong at $233.7 million, up from $200.6 million, supporting significant capital returns: HQY repurchased 2.7 million shares for $231.1 million, with $948.4 million remaining under authorization. Long‑term debt stood at $931.1 million, primarily 4.50% Senior Notes due 2029 and Revolving Credit Facility borrowings. Treasury bond forwards used as cash flow hedges generated large unrealized losses recorded in other comprehensive income, reducing accumulated other comprehensive loss to $(69.1 million).
HealthEquity, Inc. reported quarterly revenue of $354.6 million for the three months ended April 30, 2026, up 7% from a year earlier, driven mainly by an 11% increase in custodial revenue and growth in service and interchange revenue. Net income rose to $69.4 million from $53.9 million, and diluted earnings per share increased to $0.82. Adjusted EBITDA reached $164.5 million, or 46% of revenue, reflecting lower service costs from technology efficiencies.
The company administered 10.6 million HSAs and 7.2 million complementary consumer-directed benefits, with total HSA Assets of $37.1 billion, up 19%. It repurchased 1.5 million shares for $123.0 million and prepaid $15.0 million on its revolving credit facility, leaving long-term debt at $942.7 million. A $34.3 million pre-tax loss on Treasury bond forward hedges reduced accumulated other comprehensive income, but operating cash flow remained strong at $97.5 million.
HealthEquity, Inc. reports strong results for the quarter ended October 31, 2025, with total revenue of $322.2M versus $300.4M a year ago and net income of $51.7M, up from $5.7M. Diluted EPS rose to $0.59 from $0.06. For the first nine months, revenue reached $978.8M and net income $165.5M, both significantly higher than the prior year.
Adjusted EBITDA grew to $141.8M in the quarter and $433.1M year-to-date, reflecting higher gross profit and lower operating expenses after a prior-year lease settlement. The company generated operating cash flow of $339.2M, reduced long-term debt to $982.1M, and repurchased 2.4M shares for $220.0M. HealthEquity now administers 17.3M total accounts and $34.4B of HSA assets, both up year over year.
HealthEquity reported continued scale in its HSA business and active capital and risk management steps. The company administered 10.0 million HSAs with $33.1 billion of HSA Assets and 17.1 million total accounts. It completed the BenefitWallet HSA portfolio acquisition for $425.0 million, financed in part with $225.0 million of borrowings under its revolving credit facility. Deferred revenue was $11.5 million versus $17.1 million at year-end. The company uses Treasury bond forwards as cash-flow hedges to manage interest-rate exposure on expected transitions of HSA cash. Net income for the six months rose 76% year-over-year, driven by higher gross profit and lower operating expenses. Revolving credit outstanding was $411.9 million and the 4.50% senior notes fair value was $578.9 million. Management expects existing liquidity and the credit facility to be sufficient for at least the next 12 months.